296 related articles for article (PubMed ID: 12199737)
1. Valproate-induced encephalopathy: assessment with MR imaging and 1H MR spectroscopy.
Ziyeh S; Thiel T; Spreer J; Klisch J; Schumacher M
Epilepsia; 2002 Sep; 43(9):1101-5. PubMed ID: 12199737
[TBL] [Abstract][Full Text] [Related]
2. Valproate-induced metabolic changes in patients with epilepsy: assessment with H-MRS.
Garcia M; Huppertz HJ; Ziyeh S; Buechert M; Schumacher M; Mader I
Epilepsia; 2009 Mar; 50(3):486-92. PubMed ID: 19183221
[TBL] [Abstract][Full Text] [Related]
3. MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy.
Tarasów E; Panasiuk A; Siergiejczyk L; Orzechowska-Bobkiewicz A; Lewszuk A; Walecki J; Prokopowicz D
Hepatogastroenterology; 2003; 50(54):2149-53. PubMed ID: 14696484
[TBL] [Abstract][Full Text] [Related]
4. Different clinical manifestations of hyperammonemic encephalopathy.
Gomceli YB; Kutlu G; Cavdar L; Sanivar F; Inan LE
Epilepsy Behav; 2007 Jun; 10(4):583-7. PubMed ID: 17412645
[TBL] [Abstract][Full Text] [Related]
5. Valproate-induced hyperammonemic encephalopathy.
Segura-Bruna N; Rodriguez-Campello A; Puente V; Roquer J
Acta Neurol Scand; 2006 Jul; 114(1):1-7. PubMed ID: 16774619
[TBL] [Abstract][Full Text] [Related]
6. Valproate-induced hyperammonemic encephalopathy.
Murphy JV
Epilepsia; 2003 Feb; 44(2):268; author reply 268. PubMed ID: 12558587
[No Abstract] [Full Text] [Related]
7. [Valproate-induced hyperammonemic encephalopathy].
Diaz-Rangel M; Grande-Martin A; Monsalve-Naharro JA; Domingo-Chiva E; Cuesta-Montero P; Lopez-Perez A
Rev Neurol; 2017 Dec; 65(12):574-575. PubMed ID: 29235622
[TBL] [Abstract][Full Text] [Related]
8. Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy.
Simister RJ; McLean MA; Barker GJ; Duncan JS
Neurology; 2003 Oct; 61(7):897-902. PubMed ID: 14557556
[TBL] [Abstract][Full Text] [Related]
9. Quantitative short echo time proton magnetic resonance spectroscopic imaging study of malformations of cortical development causing epilepsy.
Woermann FG; McLean MA; Bartlett PA; Barker GJ; Duncan JS
Brain; 2001 Feb; 124(Pt 2):427-36. PubMed ID: 11157569
[TBL] [Abstract][Full Text] [Related]
10. 1H MR spectroscopy of the basal ganglia in childhood: a semiquantitative analysis.
Lam WW; Wang ZJ; Zhao H; Berry GT; Kaplan P; Gibson J; Kaplan BS; Bilaniuk LT; Hunter JV; Haselgrove JC; Zimmermann RA
Neuroradiology; 1998 May; 40(5):315-23. PubMed ID: 9638674
[TBL] [Abstract][Full Text] [Related]
11. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
Saksena S; Rai V; Saraswat VA; Rathore RS; Purwar A; Kumar M; Thomas MA; Gupta RK
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
[TBL] [Abstract][Full Text] [Related]
12. Fulminant progression of hyperammonaemic encephalopathy after treatment with valproate in a patient with ureterosigmoidostomy.
Schwarz S; Georgiadis D; Schwab S; Gehlen F; Mayatepek E; Zoubaa S
J Neurol Neurosurg Psychiatry; 2002 Jul; 73(1):90-1. PubMed ID: 12082063
[No Abstract] [Full Text] [Related]
13. Valproate-induced hyperammonemic encephalopathy: a case report and brief review of the literature.
Sunkavalli KK; Iqbal FM; Singh B; Koneru J
Am J Ther; 2013; 20(5):569-71. PubMed ID: 21248614
[TBL] [Abstract][Full Text] [Related]
14. Proton magnetic resonance spectroscopy in differentiating glioblastomas from primary cerebral lymphomas and brain metastases.
Chawla S; Zhang Y; Wang S; Chaudhary S; Chou C; O'Rourke DM; Vossough A; Melhem ER; Poptani H
J Comput Assist Tomogr; 2010; 34(6):836-41. PubMed ID: 21084897
[TBL] [Abstract][Full Text] [Related]
15. [Clinical uses of proton magnetic resonance spectroscopy of the brain].
Laubenberger J; Bayer S; Thiel T; Hennig J; Langer M
Rofo; 1998 Jun; 168(6):539-49. PubMed ID: 9687944
[TBL] [Abstract][Full Text] [Related]
16. [Hyperammonaemic encephalopathy due to valproic acid in the neonatal period].
Jiménez-Parrilla F; Pérez-Sánchez A; Núñez-Solís JM; Madruga-Garrido M; Losada-Martínez A
Rev Neurol; 2009 Jun 1-15; 48(11):613-4. PubMed ID: 19472163
[No Abstract] [Full Text] [Related]
17. Prognostic significance of cerebral metabolic abnormalities in patients with congestive heart failure.
Lee CW; Lee JH; Lim TH; Yang HS; Hong MK; Song JK; Park SW; Park SJ; Kim JJ
Circulation; 2001 Jun; 103(23):2784-7. PubMed ID: 11401932
[TBL] [Abstract][Full Text] [Related]
18. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.
Verma A; Saraswat VA; Radha Krishna Y; Nath K; Thomas MA; Gupta RK
Liver Int; 2008 Sep; 28(8):1095-103. PubMed ID: 18266634
[TBL] [Abstract][Full Text] [Related]
19. Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism.
McKnight TR
Semin Oncol; 2004 Oct; 31(5):605-17. PubMed ID: 15497114
[TBL] [Abstract][Full Text] [Related]
20. Valproate encephalopathy and hyperammonaemia.
O'Neill M; Dubrey RW; Grocott-Mason RM
Postgrad Med J; 2002 May; 78(919):316-7. PubMed ID: 12151592
[No Abstract] [Full Text] [Related]
[Next] [New Search]
